Cyclic changes in serum levels of insulin-like growth factor binding protein-1 in women treated with clomiphene citrate and tamoxifen

References

• Holly JMP, Wass JAH. Insulin-like growth factors: autocrine, paracrine or endocrine? New perspectives of the somatomedin hypothesis in the light of recent developments. J Endocrinol 1989; 122: 611–18
   PubMedGoogle Scholar
• Shimasaki S, Gao L, Shimonaka M, et al. Isolation and molecular cloning of insulin-like growth factor-binding protein-6. Mol Endocrinol 1991; 5: 938–48
   PubMedGoogle Scholar
• Oh Y, Nagalla SR, Yamanaka Y, et al. Synthesis and characterization of insulin-like growth factor-binding protein (IGFBP)-7. Recombinant human mac25 protein specifically binds IGF-I and -II. J Biol Chem 1996; 271: 30322–5
   PubMed Web of Science ®Google Scholar
• Wang HS, Chard T. Chromatographic characterization of insulin-like growth factor-binding proteins in human pregnancy serum. J Endocrinol 1992; 133: 149–59
   Google Scholar
• Binoux M, Hossenlopp P. Insulin-like growth factor (IGF) and IGF-binding proteins: comparison of human serum and lymph. J Clin Endocrinol Metab 1988; 67: 509–14
   Google Scholar
• El-Roeiy A, Chen X, Roberts VJ, et al. Expression of the genes encoding the insulin-like growth factors (IGF-I and II), the IGF and insulin receptors, and IGF-binding proteins-1–6 and the localization of their gene products in normal and polycystic ovary syndrome ovaries. J Clin Endocrinol Metab 1994; 78: 1488–96
   PubMed Web of Science ®Google Scholar
• Wang HS, Lee JD, Soong YK. Serum levels of insulin-like growth factor-I and insulin-like growth factor-binding protein-1 and -3 in women with regular menstrual cycles. Fertil Steril 1995; 63: 1204–9
   PubMed Web of Science ®Google Scholar
• Juul A, Scheike T, Pedersen AT, et al. Changes in serum concentrations of growth hormone, insulin, insulin-like growth factor and insulin-like growth factor-binding proteins 1 and 3 and urinary growth hormone excretion during the menstrual cycle. Hum Reprod 1997; 12: 2123–8
   PubMedGoogle Scholar
• Martikainen H, Tapanainen J, Ronnberg L, et al. Insulin-like growth factor binding protein-1 and ovarian stimulation. Hum Reprod 1991; 6: 1220–2
   Google Scholar
• Wang HS, Chard T. IGFs and IGF-binding proteins in the regulation of human ovarian and endometrial function. J Endocrinol 1999; 161: 1–13
   PubMed Web of Science ®Google Scholar
• Giudice LC, Dsupin BA, Jin IH, et al. Differential expression of messenger ribonucleic acids encoding insulin-like growth factors and their receptors in human uterine endometrium and decidua. J Clin Endocrinol Metab 1993; 76: 1115–22
   PubMed Web of Science ®Google Scholar
• Rutanen E-M, Pekonen F. Insulin-like growth factor binding protein-1 in human endometrial function. Modern Concepts of Insulin-like Growth Factors, EM Spencer. Elsevier, New York 1991; 285–94
   Google Scholar
• Adashi EY. Clomiphene citrate: mechanism(s) and site(s) of action – a hypothesis revised. Fertil Steril 1984; 42: 331–4
   PubMed Web of Science ®Google Scholar
• Clark JH, Markaverich BM. The agonistic–antagonistic properties of clomiphene: a review. Pharmacol Ther 1981; 15: 467–519
   PubMedGoogle Scholar
• Barkhem T, Carlsson B, Nilsson Y, et al. Differential response of estrogen receptor alpha and estrogen receptor beta to partial estrogen agonists/antagonists. Mol Pharmacol 1998; 54: 105–12
   PubMed Web of Science ®Google Scholar
• Wang HS, Perry LA, Kanisius J, et al. Purification and assay of insulin-like growth factor-binding protein-1: measurement of circulating levels throughout pregnancy. J Endocrinol 1991; 128: 161–8
   PubMed Web of Science ®Google Scholar
• Angervo M, Koistinen R, Suikkari A-M, et al. Insulin-like growth factor binding protein-1 inhibits the DNA amplification induced by insulin-like growth factor I in human granulosaluteal cells. Hum Reprod 1991; 6: 770–3
   Google Scholar
• Chang SY, Hiesh KC, Wang HS, et al. Follicular fluid levels of insulin-like growth factor-I, insulinlike growth factor binding protein-1 and ovarian steroids collected during ovum pick-up. Fertil Steril 1994; 62: 1162–7
   Google Scholar
• Kawano Y, Narahara H, Matsui N, et al. Insulinlike growth factor-binding protein-1 in human follicular fluid: a marker for oocyte maturation. Gynecol Obstet Invest 1997; 44: 145–8
   Google Scholar
• Nobels F, Dewailly D. Puberty and polycystic ovarian syndrome: the insulin/insulin-like growth factor I hypothesis. Fertil Steril 1992; 58: 655–66
   PubMed Web of Science ®Google Scholar
• Suikkari A-M, Koivisto VA, Rutanen E-M, et al. Insulin regulates the serum levels of low molecular weight insulin-like growth factor-binding protein. J Clin Endocrinol Metab 1988; 66: 266–72
   PubMed Web of Science ®Google Scholar
• Busby WH, Snyder DK, Clemmons DR. Radiommunoassay of a 26,000-dalton plasma insulin-like growth factor binding protein: control by nutritional variables. J Clin Endocrinol Metab 1988; 67: 1225–30
   PubMedGoogle Scholar
• McNatty KP, Makris K, De Grazia C, et al. The production of progesterone, androgens and estrogens by granulosa cells, theca tissue and stromal tissue from human ovaries in vitro. J Clin Endocrinol Metab 1979; 49: 687–99
   PubMed Web of Science ®Google Scholar
• Erickson GF, Hsueh AJW. Secretion of ‘inhibin’ by rat granulosa cells in vitro. Endocrinology 1978; 103: 1960–3
   PubMed Web of Science ®Google Scholar
• McLachlan RI, Robertson DM, Healy DL, et al. Plasma inhibin levels during gonadotropin-induced ovarian hyperstimulation for IVF: a new index of follicular function?. Lancet 1986; 1: 1233–4
   Google Scholar
• Fukushima T, Maeyama M. Action of tamoxifen on folliculogenesis in the menstrual cycle of infertile patients. Fertil Steril 1983; 40: 210–14
   Google Scholar
• Tajima C. Luteotropic effects of tamoxifen in infertile women. Fertil Steril 1984; 42: 233–7
   Google Scholar
• Viniker DA. Late luteal phase dydrogesterone in combination with clomiphene or tamoxifen in the treatment of infertility associated with irregular and infrequent menstruation: enhancing patient compliance. Hum Reprod 1996; 11: 1435–7
   Google Scholar
• Tan SL, Jacobs HS. Infertility: Your Questions Answered. McGraw-Hill, Singapore 1991; 76
   Google Scholar
• Gulekli B, Oaksit G, Turhan NO, et al. Tamoxifen: an alternative approach in clomiphene resistant polycystic ovary syndrome patients. J Pak Med Assoc 1993; 43: 89–90
   PubMedGoogle Scholar
• Borenstein R, Shoham Z, Yemini M, et al. Tamoxifen treatment in women with failure of clomiphene citrate therapy. Aust NZ Obstet Gynecol 1989; 29: 173–5
   PubMed Web of Science ®Google Scholar
• Suginami H, Kitagawa H, Nakahashi N, et al. A clomiphene citrate and tamoxifen citrate combination therapy: a novel therapy for ovulation induction. Fertil Steril 1993; 59: 976–9
   PubMed Web of Science ®Google Scholar
• McLachlan RI, Robertson DM, Healy DL, et al. Circulating immunoreactive inhibin levels during the normal human menstrual cycle. J Clin Endocrinol Metab 1987; 65: 954–61
   PubMed Web of Science ®Google Scholar
• De Kreser DM, Robertson DM. The isolation and physiology of inhibin and related proteins. Biol Reprod 1989; 40: 33–47
   Google Scholar
• Pellicer A, Mart M, de los Santos MJ, et al. Effects of aging on the human ovary: the secretion of immunoreactive α-inhibin and progesterone. Fertil Steril 1994; 61: 663–8
   Google Scholar
• Balasch J, Creus M, Fábregues F, et al. Midluteal immunoreactive α-inhibin serum concentrations as markers of luteal phase deficiency. Hum Reprod 1996; 11: 2591–4
   Google Scholar
• Ying S-Y. Inhibins, activins, and follistatins: gonadal proteins modulating the secretion of follicle-stimulating hormone. Endocr Rev 1988; 9: 267–93
   PubMed Web of Science ®Google Scholar
• Thierry van Dessel HJHM, Chandrasekher Y, Yap OWS, et al. Serum and follicular fluid levels of insulin-like growth factor-I (IGF-I), IGF-II, and IGF-binding protein-1 and -3 during the normal menstrual cycle. J Clin Endocrinol Metab 1996; 81: 1224–31
   PubMedGoogle Scholar
• Helle SI, Anker GB, Meadows KA, et al. Alterations in the insulin-like growth factor system during the menstrual cycle in normal women. Maturitas 1998; 28: 259–65
   Google Scholar